Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial Download the PDF here. This post...
Read moreBrightstar Resources (BTR:AU) has announced Investor Presentation Annual General Meeting Download the PDF here. This post appeared first on investingnews.com
Read moreChariot Corporation (CC9:AU) has announced Black Mountain Phase 2 Program has Commenced Download the PDF here. This post appeared first...
Read moreFor thousands of years, coal has been an important source of heat and energy. The fossil fuel played a crucial...
Read moreCleanTech Lithium PLC (AIM:CTL), an exploration and development company advancing next-generation sustainable lithium projects in Chile for the EV transition,...
Read moreCyprium Metals Limited (ASX: CYM, OTC: CYPMF) is pleased to present the Prefeasibility Study (“PFS”) for the Nifty Copper Complex. The...
Read moreRadiopharm Theranostics (RAD:AU) has announced Radiopharm achieves Nasdaq listing of ADS Download the PDF here. This post appeared first on...
Read moreNewmont (TSX:NGT,NYSE:NEM), the world’s largest gold miner, is continuing its divestiture program through the sale of its Éléonore mine in...
Read moreRua Gold Inc. (TSXV: RUA) (OTCQB: NZAUF) (WKN: A4010V) (‘RUA GOLD‘ or the ‘Company’) is pleased to announce the completion...
Read moreEli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) (‘Zero Candida’ or the ‘Company’), joined Dani...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved